1. Home
  2. AGEN vs SKIN Comparison

AGEN vs SKIN Comparison

Compare AGEN & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.23

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo The Beauty Health Company

SKIN

The Beauty Health Company

HOLD

Current Price

$0.60

Market Cap

123.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
SKIN
Founded
1994
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
123.9M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
AGEN
SKIN
Price
$3.23
$0.60
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$14.50
$2.03
AVG Volume (30 Days)
672.7K
1.5M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
55.56
EPS
1.02
N/A
Revenue
$42,877,086.00
$300,790,000.00
Revenue This Year
$107.63
$0.88
Revenue Next Year
N/A
$4.60
P/E Ratio
$3.33
N/A
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$0.55
52 Week High
$7.34
$2.69

Technical Indicators

Market Signals
Indicator
AGEN
SKIN
Relative Strength Index (RSI) 42.85 37.76
Support Level $2.93 $0.57
Resistance Level $3.26 $0.88
Average True Range (ATR) 0.22 0.08
MACD 0.01 -0.00
Stochastic Oscillator 36.93 4.21

Price Performance

Historical Comparison
AGEN
SKIN

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About SKIN The Beauty Health Company

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

Share on Social Networks: